IKT
Inhibikase Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.50
−0.79%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
+53.1%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Jul 31, 2026 | BERMAN DENNIS N · director | M-Exempt | 21,854 | $1.26 |
| Jun 30, 2026 | BERMAN DENNIS N · director | A-Award | 155,000 | $1.91 |
| Jun 30, 2026 | Munshi Amit · director | A-Award | 155,000 | $1.91 |
| Jun 30, 2026 | Aurentz Vincent · director | A-Award | 155,000 | $1.91 |
| Jun 30, 2026 | Bellini Roberto · director | A-Award | 155,000 | $1.91 |
| Jun 30, 2026 | Kush Arvind · director | A-Award | 155,000 | $1.91 |
| Jun 30, 2026 | Canner David · director | A-Award | 155,000 | $1.91 |
| Jan 7, 2026 | McIntyre David · officer: Chief Financial Officer | A-Award | 986,319 | $2.01 |
| Jan 7, 2026 | Cabell Christopher · officer: President & Head of R&D | A-Award | 900,117 | $2.01 |
| Jan 7, 2026 | Iwicki Mark T · director, officer: Chief Executive Officer | A-Award | 4,982,706 | $2.01 |
| Nov 24, 2025 | Sands Capital Life Sciences Pulse Fund II, L.P. · 10 percent owner | Purchase | 2,068,965 | $1.45 |
| Aug 28, 2025 | Munshi Amit · director | A-Award | 57,265 | $0.00 |
| Jul 2, 2025 | BERMAN DENNIS N · director | A-Award | 108,176 | $1.95 |
| Jul 2, 2025 | Canner David · director | A-Award | 108,176 | $1.95 |
| Jul 2, 2025 | Munshi Amit · director | A-Award | 108,176 | $1.95 |
| Jul 2, 2025 | Kush Arvind · director | A-Award | 108,176 | $1.95 |
| Jul 2, 2025 | Aurentz Vincent · director | A-Award | 108,176 | $1.95 |
| Jul 2, 2025 | Bellini Roberto · director | A-Award | 108,176 | $1.95 |
| Jul 2, 2025 | Cabell Christopher · officer: President & Head of R&D | A-Award | 1,100,705 | $2.97 |
| Jul 2, 2025 | Iwicki Mark T · director, officer: Chief Executive Officer | A-Award | 602,346 | $2.97 |
| Jul 2, 2025 | Aurentz Vincent · director | A-Award | 134,427 | $2.97 |
| Apr 16, 2025 | McIntyre David · officer: Chief Financial Officer | A-Award | 1,775,539 | $2.00 |
| Feb 25, 2025 | Cabell Christopher · officer: President & Head of R&D | A-Award | 1,100,705 | $2.23 |
| Feb 25, 2025 | Aurentz Vincent · director | A-Award | 134,427 | $2.23 |
| Feb 25, 2025 | Iwicki Mark T · director, officer: Chief Executive Officer | A-Award | 602,346 | $2.23 |
| Feb 19, 2025 | Munshi Amit · director | A-Award | 116,585 | $2.35 |
| Feb 19, 2025 | Munshi Amit · director | A-Award | 56,600 | $2.35 |
| Feb 19, 2025 | Canner David · director | A-Award | 116,585 | $2.35 |
| Feb 19, 2025 | Canner David · director | A-Award | 22,640 | $2.35 |
| Feb 19, 2025 | BERMAN DENNIS N · director | A-Award | 39,620 | $2.35 |
Institutional positioning
13F filings over the trailing two quarters
New 39Increased 38Reduced 16Sold out 100
| Filer | Action | Shares | Filed |
|---|---|---|---|
| SANDS CAPITAL VENTURES, LLC | Unchanged | 13,018,965 | May 8, 2026 |
| SOLEUS CAPITAL MANAGEMENT, L.P. | Unchanged | 10,875,000 | May 14, 2026 |
| FAIRMOUNT FUNDS MANAGEMENT LLC | Unchanged | 8,625,000 | May 15, 2026 |
| Trails Edge Capital Partners, LP | Increased | 8,057,345 | May 15, 2026 |
| ADAR1 CAPITAL MANAGEMENT, LLC | Reduced | 6,606,572 | May 18, 2026 |
| BLACKROCK, INC. | Increased | 6,303,433 | May 13, 2026 |
| BLACKSTONE INC. | Unchanged | 5,938,276 | May 15, 2026 |
| SIREN, L.L.C. | Unchanged | 5,850,000 | May 14, 2026 |
| COMMODORE CAPITAL LP | Unchanged | 5,397,488 | May 15, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 4,450,665 | May 15, 2026 |
| SATURN V CAPITAL MANAGEMENT LLC | Increased | 3,863,445 | May 15, 2026 |
| Kalehua Capital Management LLC | Increased | 3,821,890 | May 15, 2026 |
| Spruce Street Capital LP | Unchanged | 3,581,603 | May 14, 2026 |
| Squadron Capital Management LLC | Reduced | 3,500,000 | May 15, 2026 |
| MILLENNIUM MANAGEMENT LLC | Increased | 2,928,077 | May 15, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jul 31, 2026